Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Haemophilia, Experiences, Results and Opportunities (HERO): A Community-based Evaluation of the Psychosocial Effects of Haemophilia on Patients and Their Carers

NCT01322620 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT01322620
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01322620 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Haemophilia, Experiences, Results and Opportunities (HERO): A Community-based Evaluation of the Psychosocial Effects of Haemophilia on Patients and Their Carers
Lead sponsor
Novo Nordisk A/S
Phase
Observational
Overall status
Completed
Start date
June 3, 2011
Completion date
February 29, 2012
Enrollment
1,236 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

congenital bleeding disorder, haemophilia a, haemophilia a with inhibitors, haemophilia b, haemophilia b with inhibitors, relatives to/carers of patients